Newswise — UCLA scientists have developed a simple and cost-effective blood test that, in early studies, shows promise in detecting multiple cancers, various liver conditions and organ abnormalities ...

Researchers at the University of California, Los Angeles have published a new blood test designed to detect multiple cancers and other diseases from a single, low-cost sample. The study, which ...

Newswise — Biologic drugs play an important role in treating cancers such as breast cancer and lymphoma, but their high costs can add to the financial burden of cancer care. Now, lower-cost versions ...

A UCLA study found patients with cancer who used biosimilars paid less out of pocket, and their insurers paid far less, than those on brand-name biologics. Patients with cancer who used biosimilar ...

This post was updated September 7 at 8:14 p.m. UCLA plans to consolidate campus human resources, finance, communications, marketing, event planning and academic personnel services to cut costs, ...